Events and Webinars
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
Marcella Seto Chock, Pharm.D.
Health Outcomes Liaison, Vaccines
Marcella has been with GSK since October 2014. Marcella is born and raised in Honolulu, HI and now resides in Portland, OR. She is married with 2 children. She earned her doctorate in pharmacy at the University of the Pacific in Stockton, CA and fellowship from the Executive Management Program for Pharmacy Leaders at the Wharton School, University of Pennsylvania. She’s held various board appointments within the state of Hawaii, as well faculty appointments for various schools of pharmacy. She has worked as a clinical pharmacist in the VA and Kaiser, medical outcomes specialist for industry. Prior to joining GSK she was a pharmacy director for a national managed Medicaid and Medicare health plan in the Hawaii market.
- 1h 30m
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.Related Events and Webinars
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
IMPORTANT SAFETY INFORMATION
- SHINGRIX is contraindicated in anyone with a history of a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine or after a previous dose of SHINGRIX
- Review immunization history for possible vaccine sensitivity and previous vaccination-related adverse reactions. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of SHINGRIX
- Solicited local adverse reactions in subjects aged 50 years and older were pain (78.0%), redness (38.1%), and swelling (25.9%)
- Solicited general adverse reactions in subjects aged 50 years and older were myalgia (44.7%), fatigue (44.5%), headache (37.7%), shivering (26.8%), fever (20.5%), and gastrointestinal symptoms (17.3%)
- SHINGRIX was not studied in pregnant or lactating women, and it is unknown if it is excreted in human milk. Therefore, it cannot be established whether there is vaccine-associated risk with SHINGRIX in pregnant women or if there are effects on breastfed infants or milk production/excretion
- Vaccination with SHINGRIX may not result in protection of all vaccine recipients
Trademarks are property of their respective owners.
827007R0 October 2017
INDICATION
SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older.
SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).